TriSalus Life Sciences (TLSI) Other Accumulated Expenses (2022 - 2026)

TriSalus Life Sciences' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $269000.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 36.85% year-over-year to $269000.0 in Q1 2026; TTM through Mar 2026 was $269000.0, a 36.85% decrease from a year earlier, with the FY2025 full-year figure at $234000.0, down 38.9% from the prior year.
• Other Accumulated Expenses improved to $269000.0 in Q1 2026 per TLSI's latest filing, from $234000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $427000.0 in Q3 2023 and bottomed at $142000.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $280000.0 (2024), against an average of $299583.3.
• Across the five-year window, Other Accumulated Expenses surged 173.94% in 2023 and plunged 38.9% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $142000.0 in 2022, then jumped by 173.94% to $389000.0 in 2023, then declined by 1.54% to $383000.0 in 2024, then slumped by 38.9% to $234000.0 in 2025, then rose by 14.96% to $269000.0 in 2026.
• Per Business Quant, the three latest TLSI Other Accumulated Expenses figures stand at $269000.0 (Q1 2026), $234000.0 (Q4 2025), and $224000.0 (Q3 2025).